BACE1 and Alzheimer disease: In conclusion, thetubular form with a stopper group shows great potential for the treatmentof Alzheimer’s disease, as it blocks the entrance cavity ofthe AChE active pocket for the substrate and increases the stabilityof the inactive BACE-1 enzyme.